Drug Approval | April 21, 2026
Orbicular's partner secures tentative U.S. ANDA approval for a generic version of Ozempic
OneSource is the contract development and manufacturing organization (CDMO) partner for this product
OneSource is the contract development and manufacturing organization (CDMO) partner for this product
The programme has already drawn over 120 complex percutaneous coronary intervention (PCI) case submissions from across the country
The approved product is a generic version of Ravicti, originally developed and marketed by Horizon Therapeutics
Bolli will lead worldwide business development for the company’s Contract Development and Manufacturing Organisation (CDMO) services
Bajaj joins Health Prime after a long and progressive tenure at Concentrix
The launch coincides with IBS Awareness Month in April
Move to accelerate cancer care expansion across India
PMDA is regarded among the most stringent regulatory bodies globally
Narasimhan’s appointment underscores the growing importance of AI in transforming drug discovery
The innovation is particularly suited for bone and cartilage repair
Subscribe To Our Newsletter & Stay Updated
